Haelixa vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 23)

Haelixa

EmergingLuxury Goods

General

Zurich ETH Zurich spin-off DNA supply chain traceability (founded 2016); $1.5M 2024 revenue (+84%) tracking 30M+ garments for C&A/Soorty with forensic-grade origin verification competing with Applied DNA Sciences for EU textile compliance.

AI VisibilityBeta
Overall Score
D23
Category Rank
#455 of 1167
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
24
Perplexity
21
Gemini
23

About

Haelixa is a Zurich, Switzerland-based physical supply chain traceability company — an ETH Zurich spin-off founded in 2016 by PhD researchers — embedding DNA markers into textiles, precious materials, and luxury goods to provide forensic-grade authentication and origin verification that remains detectable through washing, processing, manufacturing, and global distribution. Founded by Michela Puddu (CEO) and CTO Gediminas Mikutis, with new CEO Patrick Strumpf and Stefan Karlen joining the Board in 2024-2025, Haelixa has grown to 17 employees and achieved $1.5 million in 2024 revenue (up 84% from $815,000 in 2023), tracking over 30 million garments globally for partners including C&A, Soorty Enterprises, Oerlikon, Damteks, and regenagri. The company has raised seed funding from investiere and Zurich Cantonal Bank and won 20+ international awards. Haelixa's DNA markers are engineered to be non-toxic, vegan, and biodegradable — validated through laboratory spectroscopy analysis providing forensic-grade proof of origin.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

23
Overall Score
90
#455
Category Rank
#9
67
AI Consensus
60
stable
Trend
stable
24
ChatGPT
99
21
Perplexity
99
23
Gemini
83
33
Claude
96
19
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.